Source: Pharmacy Times articles
A panelist discusses how physicians can recognize the burden of RSV in high-risk populations, stay informed about preventive strategies such as vaccines and monoclonal antibodies, and apply clinical insights to reduce severe outcomes and hospitalizations.
Read More